Pulmonary Perspectives®
Pulmonary Perspectives®
Which biologic therapy should I use in patients who have moderate to severe asthma with associated comorbidities?
As new treatments for specific moderate to severe asthma phenotypes have been developed, management decisions have grown more complicated.
Pulmonary Perspectives®
Cardiopulmonary exercise testing for unexplained dyspnea
Unexplained dyspnea is a common complaint among patients seen in pulmonary clinics, and can be difficult to define.
Pulmonary Perspectives®
Relearning old lessons from a new disease: Prolonged noninvasive respiratory support for hypoxemic respiratory failure can harm patients
Prolonged noninvasive respiratory support in patients who ultimately require invasive mechanical ventilation may likely be deleterious.
Pulmonary Perspectives®
COVID-19 ECMO and right ventricular failure: Lessons learned and standardization of management
Many of those with RV changes on TTE did not progress to clinical failure..
Pulmonary Perspectives®
Race and spirometry
The document builds on past work and integrates new advances the field has seen since 2005.
Pulmonary Perspectives®
Advanced POCUS for us all?
It’s unclear whether all fellowship-trained physicians can and should be tasked with obtaining official POCUS certification.
Pulmonary Perspectives®
Updates on eosinophilia in asthma
Pulmonary Perspectives®
Continuous remote patient monitoring
Pulmonary Perspectives®
Inhaled corticosteroids for COVID-19
Over time, OCS therapy has gained acceptance as a treatment for moderate-to-severe COVID-19.
Pulmonary Perspectives®
Transitioning from fellow to attending